Seres Therapeutics (MCRB) Shares Outstanding (2016 - 2025)
Seres Therapeutics (MCRB) has disclosed Shares Outstanding for 11 consecutive years, with $9.6 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding rose 10.48% to $9.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.6 million through Dec 2025, up 10.48% year-over-year, with the annual reading at $9.6 million for FY2025, 10.48% up from the prior year.
- Shares Outstanding hit $9.6 million in Q4 2025 for Seres Therapeutics, up from $8.8 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $128.6 million in Q3 2023 to a low of $6.3 million in Q4 2022.
- Historically, Shares Outstanding has averaged $57.0 million across 5 years, with a median of $50.6 million in 2021.
- Biggest five-year swings in Shares Outstanding: soared 38.71% in 2023 and later tumbled 94.08% in 2024.
- Year by year, Shares Outstanding stood at $91.9 million in 2021, then tumbled by 93.19% to $6.3 million in 2022, then increased by 7.84% to $6.8 million in 2023, then increased by 28.11% to $8.7 million in 2024, then rose by 10.48% to $9.6 million in 2025.
- Business Quant data shows Shares Outstanding for MCRB at $9.6 million in Q4 2025, $8.8 million in Q3 2025, and $8.8 million in Q2 2025.